StemGen, Inc. announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced sales was USD 15,000 compared to USD 1,750 a year ago. Operating loss was USD 48,410 compared to USD 20,843 a year ago. Net loss was USD 114,840 compared to USD 61,767 a year ago. For the half year, sales was USD 39,000 compared to USD 1,750 a year ago. Operating loss was USD 94,154 compared to USD 34,024 a year ago. Net loss was USD 201,514 compared to USD 115,879 a year ago.